BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang H, Zhou W, Zhu H, Zhou P, Shi X. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs. Toxicol Appl Pharmacol 2017;323:36-43. [PMID: 28322895 DOI: 10.1016/j.taap.2017.03.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Xia C, Tang W, Geng P, Zhu H, Zhou W, Huang H, Zhou P, Shi X. Baicalin down-regulating hepatitis B virus transcription depends on the liver-specific HNF4α-HNF1α axis. Toxicol Appl Pharmacol 2020;403:115131. [PMID: 32687838 DOI: 10.1016/j.taap.2020.115131] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Xu Q, Zhou A, Wu H, Bi Y. Development and in vivo evaluation of baicalin-loaded W/O nanoemulsion for lymphatic absorption. Pharm Dev Technol 2019;24:1155-63. [PMID: 31342830 DOI: 10.1080/10837450.2019.1646757] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
3 Komolafe K, Komolafe TR, Fatoki TH, Akinmoladun AC, Brai BIC, Olaleye MT, Akindahunsi AA. Coronavirus Disease 2019 and Herbal Therapy: Pertinent Issues Relating to Toxicity and Standardization of Phytopharmaceuticals. Rev Bras Farmacogn 2021;:1-20. [PMID: 33727754 DOI: 10.1007/s43450-021-00132-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Haider M, Hassan MA, Ahmed IS, Shamma R. Thermogelling Platform for Baicalin Delivery for Versatile Biomedical Applications. Mol Pharm 2018;15:3478-88. [PMID: 29953815 DOI: 10.1021/acs.molpharmaceut.8b00480] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
5 Li S, Liu C, Guo F, Taleb SJ, Tong M, Shang D. Traditional Chinese Medicine as Potential Therapy for COVID-19. Am J Chin Med 2020;48:1263-77. [PMID: 32907358 DOI: 10.1142/S0192415X20500627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
6 Zhao QY, Yuan FW, Liang T, Liang XC, Luo YR, Jiang M, Qing SZ, Zhang WM. Baicalin inhibits Escherichia coli isolates in bovine mastitic milk and reduces antimicrobial resistance. J Dairy Sci 2018;101:2415-22. [PMID: 29290430 DOI: 10.3168/jds.2017-13349] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
7 Ahmed IS, Rashed HM, Fayez H, Farouk F, Shamma RN. Nanoparticle-Mediated Dual Targeting: An Approach for Enhanced Baicalin Delivery to the Liver. Pharmaceutics 2020;12:E107. [PMID: 32013203 DOI: 10.3390/pharmaceutics12020107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
8 Ye L, Zhang J, Xiao W, Liu S. Efficacy and mechanism of actions of natural antimicrobial drugs. Pharmacol Ther 2020;216:107671. [PMID: 32916205 DOI: 10.1016/j.pharmthera.2020.107671] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cai Y, Ma W, Xiao Y, Wu B, Li X, Liu F, Qiu J, Zhang G. High doses of baicalin induces kidney injury and fibrosis through regulating TGF-β/Smad signaling pathway. Toxicol Appl Pharmacol 2017;333:1-9. [PMID: 28803990 DOI: 10.1016/j.taap.2017.08.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
10 Lv X, Xiang X, Wu Y, Liu Y, Xu R, Xiang Q, Lai G. GATA binding protein 4 promotes the expression and transcription of hepatitis B virus by facilitating hepatocyte nuclear factor 4 alpha in vitro. Virol J 2021;18:196. [PMID: 34583732 DOI: 10.1186/s12985-021-01668-z] [Reference Citation Analysis]
11 Anand AV, Balamuralikrishnan B, Kaviya M, Bharathi K, Parithathvi A, Arun M, Senthilkumar N, Velayuthaprabhu S, Saradhadevi M, Al-Dhabi NA, Arasu MV, Yatoo MI, Tiwari R, Dhama K. Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2. Molecules 2021;26:1775. [PMID: 33809963 DOI: 10.3390/molecules26061775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Yang JY, Li M, Zhang CL, Liu D. Pharmacological properties of baicalin on liver diseases: a narrative review. Pharmacol Rep 2021;73:1230-9. [PMID: 33595821 DOI: 10.1007/s43440-021-00227-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Ben-Shabat S, Yarmolinsky L, Porat D, Dahan A. Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies.Drug Deliv Transl Res. 2020;10:354-367. [PMID: 31788762 DOI: 10.1007/s13346-019-00691-6] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 55.0] [Reference Citation Analysis]
14 Qian K, Kong ZR, Zhang J, Cheng XW, Wu ZY, Gu CX, Shao HX, Qin AJ. Baicalin is an inhibitor of subgroup J avian leukosis virus infection. Virus Res 2018;248:63-70. [PMID: 29481814 DOI: 10.1016/j.virusres.2018.02.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
15 Ortega JT, Serrano ML, Suárez AI, Baptista J, Pujol FH, Cavallaro LV, Campos HR, Rangel HR. Antiviral activity of flavonoids present in aerial parts of Marcetia taxifolia against Hepatitis B virus, Poliovirus, and Herpes Simplex Virus in vitro. EXCLI J 2019;18:1037-48. [PMID: 31762727 DOI: 10.17179/excli2019-1837] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
16 Li X, Zhou D, Chi X, Li Q, Wang L, Lu B, Mao D, Wu Q, Wang X, Zhang M, Xue J, Li Y, Lu W, Guo J, Jiang F, Zhang X, Li Z, Yang X, Guo H, Gan D, He L, Luo L, Zhang L, Du H, Ye Y. Entecavir combining Chinese herbal medicine for HBeAg-positive chronic hepatitis B patients: a randomized, controlled trial. Hepatol Int 2020;14:985-96. [PMID: 33128206 DOI: 10.1007/s12072-020-10097-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Hu Q, Zhang W, Wu Z, Tian X, Xiang J, Li L, Li Z, Peng X, Wei S, Ma X, Zhao Y. Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects. Pharmacol Res 2021;165:105444. [PMID: 33493657 DOI: 10.1016/j.phrs.2021.105444] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Chirumbolo S. Baicalin in flavocoxid may act against hepatitis B virus via a pro-inflammatory pathway. Inflamm Res 2018;67:203-5. [DOI: 10.1007/s00011-017-1111-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zheng J, Xu Y, Khan A, Wang S, Li H, Sun N. In vitro Screening of Traditional Chinese Medicines Compounds Derived with Anti-encephalomyocarditis Virus Activities. Biotechnol Bioproc E 2020;25:181-9. [DOI: 10.1007/s12257-019-0354-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]